Article

Identification of Transcriptional Regulators of Immune Evasion across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma

2024-10-16

Abstract excerpt

<h4>Background: </h4> Immune evasion in cancer is a multifaceted process that synchronizes pro-tumoral immune infiltration, immunosuppressive inflammation, and inhibitory immune checkpoint expression (IC). Recent developments have immunotherapies such as immune checkpoint blockade (ICB) and chimeric antigen receptor T-cell (CAR-T) therapy effectively impede this process but benefit a limited patient cohort. This i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 71ceb909-9d3b-578b-964d-57af2fc9072a
DOI: 10.20944/preprints202410.1274.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Transcriptional Regulators of Immune Evasion across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaDOI 10.20944/preprints202410.1274.v1Read

The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel ImmunotherapiesSemantic proximity Read

TIGIT drives the immunosuppressive environment by downregulation of metalloproteinases MMP2 and MMP14 in perihilar cholangiocarcinomaSemantic proximity Read

Immunogenomics of cholangiocarcinomaSemantic proximity Read

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.Semantic proximity Read

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma.Semantic proximity Read

Integrating cell interaction with transcript factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinomaSemantic proximity Read

Multimodal single-cell profiling reveals cancer crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patientsSemantic proximity Read

Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologiesSemantic proximity Read

Proteogenomic characterization reveals antitumor mechanisms of intrahepatic cholangiocarcinomaSemantic proximity Read

Heterogeneity of Cholangiocarcinoma Immune BiologySemantic proximity Read

PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing TechnologySemantic proximity Read

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapySemantic proximity Read